Form 4 Cingulate Inc For: 2 July
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cingulate Inc (CING)
Track today's live Cingulate (CING) share price, performance and key data on this page with our current NASDAQ:CING stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Cingulate share price on the NASDAQ exchange. Use the dropdown to switch exchange for the CING share price, head to our technical summary section, which provides analysis on Cingulate share price buy/sell indicators using real-time data (or discuss the Cingulate (CING) stock price today with other investors in the Cingulate NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:CING share price (ISIN: US17248W3034) to enhance your trading decisions with our free investment tools and resources.
What Is the Cingulate Inc Share Price Today?
The Cingulate share price today is 5.300.
What Is the Stock Symbol for Cingulate Inc
The stock symbol (or 'ticker') for Cingulate Inc is "CING."
What Stock Exchange Does Cingulate Inc Trade On?
Cingulate Inc is listed and trades on the NASDAQ stock exchange.
Is Cingulate Inc a Good Stock to Buy?
Determining whether Cingulate (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:CING share price (ISIN: US17248W3034) to enhance your trading decisions with our free investment tools and resources.
What Is the Cingulate Inc Share Price Today?
The Cingulate share price today is 5.300.
What Is the Stock Symbol for Cingulate Inc
The stock symbol (or 'ticker') for Cingulate Inc is "CING."
What Stock Exchange Does Cingulate Inc Trade On?
Cingulate Inc is listed and trades on the NASDAQ stock exchange.
Is Cingulate Inc a Good Stock to Buy?
Determining whether Cingulate (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.230
5.650
52 wk Range
3.160
11.890
CING is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.2305.650
52 wk Range
3.16011.890
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CING Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
23.000
Upside
+333.96%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
- Cingulate added to Russell 3000E Index
- Investing.com
- Form 4 Cingulate Inc For: 2 July
- Investing.com
- Cingulate added to Russell 3000E Index
- Investing.com
- Form 8K Cingulate Inc For: 16 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 23.000
(+333.96% Upside)
Earnings
Latest Release
14/05/2026
EPS / Forecast
-0.95 / -0.48
Revenue / Forecast
-- / --
Compare CING to Peers and Sector
Metrics to compare | CING | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCINGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.6x | −3.0x | −0.4x | |
PEG Ratio | −0.06 | −0.05 | 0.00 | |
Price/Book | 3.8x | 1.8x | 2.6x | |
Price / LTM Sales | - | 1.5x | 3.0x | |
Upside (Analyst Target) | 271.7% | 143.9% | 49.1% | |
Fair Value Upside | Unlock | 13.3% | 6.3% | Unlock |
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company’s lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Cingulate (NASDAQ: CING) Share Price Today?
The Cingulate stock price today is 5.300 USD.
What Stock Exchange Does Cingulate (CING) Trade On?
Cingulate is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Cingulate?
The stock symbol (also called a 'ticker') for Cingulate is "CING."
What Is the Current Cingulate Market Capitalisation?
As of today, Cingulate (NASDAQ: CING) market cap is 72.460M USD.
What Is Cingulate's (CING) Earnings Per Share (TTM)?
The Cingulate EPS is currently -4.236 (Trailing Twelve Months).
When Is the Next Cingulate Earnings Date?
Cingulate's next earnings report will be released on 18/08/2026.
Is CING a Buy or Sell From a Technical Analyst Perspective?
Based on today's Cingulate moving averages and other technical indicators, the daily buy/sell signal for CING stock is Buy.
How Many Times Has Cingulate Stock Split?
Cingulate has split 2 times. (See the CING stock split history page for full effective split date and price information.)
How Many Employees Does Cingulate Have?
Cingulate has 14 employees, based on their latest Companies House report.
What is the current trading status of Cingulate (NASDAQ: CING)?
As of 06/07/2026, Cingulate (CING) is trading at a share price of 5.300 USD, with a previous close of 5.380 USD. The stock has fluctuated within a day range of 5.230 USD to 5.650 USD, while its 52-week range spans from 3.160 USD to 11.890 USD.
What Is Cingulate (CING) Price Target According to Analysts?
The average 12-month price target for Cingulate is 23.000 USD, with a high estimate of 52 USD and a low estimate of 8 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +333.96% Upside potential.
What Is the CING Premarket Price?
CING's last pre-market stock price is 5.390 USD. The pre-market share volume is 2,060.000, and the stock has decreased by 0.010, or 0.190%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.